Interface Biosciences

3 known investors

Interface Bio develops immunotherapies targeting complex inflammatory diseases by combining biological evolution, metabolomics, and machine learning to discover natural-derived therapeutic products.

AI & Machine LearningBiotechDeep TechMedical Devices